Search anything
Welcome to Multibagg AI
Log in to access personalized features
Welcome to Multibagg AI
Log in to access personalized features
Dashboard
Portfolio
Ask Iris
Discovery
Timeline
Multibagg AI is an AI powered stock research and analysis platform. We provide data, information, content, and analytics for publicly traded Indian companies listed on NSE and BSE. AI can make mistakes, check important information.
Prices might be delayed by a few minutes.
Join our Exclusive Community
Join our Exclusive Community
Made with 💙 in India. © Finsky Technologies Pvt Ltd. 2026
Latest stock market news, company updates, and price movements. Stay updated with market trends, earnings insights, and investment analysis.
Hindustan Unilever will meet on April 30, 2026 to approve audited FY26 results and consider a final dividend, followed by an analyst and investor presentation.
Balrampur Chini Mills approved a ₹450 crore preferential issue, raised PLA project capex to ₹3,080 crore, and cleared a ₹160 crore lactogypsum plant in Uttar Pradesh.
IKS Health’s US unit will acquire TruBridge for $26.25 a share in cash, a deal valued around $565 million, subject to shareholder approvals and HSR clearance.
Gujarat Themis Biosyn signed an asset purchase agreement with Sanofi to buy 13 anti-TB and anti-infective brands for EUR 158 million, subject to approvals.
Indian benchmarks opened higher on Monday after a volatile, holiday-shortened week, with mixed global cues, conflicting GIFT Nifty signals, and continued FII selling in focus.
Nifty 50 ended at 24,173.05, down 0.84% after moving between 24,134.80 and 24,310.20, while Bank Nifty fell 1.43% and the rupee strengthened.
A Budget 2026 debate is building around optional joint income tax returns for married couples, aimed at reducing the gap between single- and dual-income households.
Balrampur Chini approved a Rs 450 crore preferential issue, a Rs 200 crore NCD plan, higher PLA project capex, and a new Rs 160 crore lactogypsum plant in UP.
Balrampur Chini Mills approved a ₹450 crore preferential issue, up to ₹200 crore NCD plan, ₹160 crore lactogypsum plant, and higher PLA project capex in UP.
HDFC Life will allot 1.45 crore shares to promoter HDFC Bank for ₹1,000 crore at ₹688.52, raising the bank’s holding above 50% post-issue.
HDFC Life’s FY26 concall outlined Q4 growth softness from GST and bancassurance, while highlighting protection momentum, stable persistency, ₹4,034 crore VNB, and a ₹2.10 dividend.
Gujarat Themis Biosyn signed an asset purchase agreement with Sanofi to acquire 13 anti-TB and anti-infective brands for EUR 158 million, targeting closing by December 2026.
Brent and WTI rallied after an unconfirmed report said Iran’s chief negotiator Mohammad Bagher Ghalibaf resigned, reviving fears around Strait of Hormuz restrictions.
With the Nifty IT index down nearly 20% in three months, brokerages expect muted Q4FY26 growth, modest YoY recovery, and tight focus on FY27 guidance.
Microsoft buyouts, Meta job cuts, and Intel’s upbeat revenue outlook show how Big Tech is reshaping costs while funding large artificial intelligence investments in 2026.
QuantumScape shares jumped after a Q1 EPS beat and pilot-line progress update, even as mixed analyst ratings, high short interest, and insider selling keep risks in focus.
